Delcath Systems Inc.

DCTH | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.29

+$0.18 (+1.12%)

Sep 22, 2026, 9:57 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.12%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $562.36M

1D Range

16.07 16.30

52W Range

8.12 17.42

Valuation (TTM)

PE 1.24K

PB 4.59

EV/EBITDA 272.98

Valuation (NTM)

Forward PE 14.75

Forward PEG -21.79

Price Target $24.50

Cash Flow

FCF Yield 3.2%

SBC Adj. FCF Yield -1.3%

SBC Impact -141.5%

Margins

Gross Margin 87.0%

Operating Margin -1.9%

FCF Margin 18.6%

Growth (CAGR)

Revenue 3Y | 5Y 230.8% | 118.9%

Dil EPS 3Y | 5Y 153.5% | 64.0%

FCF 3Y | 5Y 751.1% | 94.3%

Returns

ROA 0.4%

ROE 0.5%

ROIC -0.6%

Financial Health

Net Cash

$93.44M

Current Ratio 9.83

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investi...

Sector Healthcare

Industry Medical - Devices

Employees 156

IPO Date May 2, 2018

Website www.delcath.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.